Francois is chairman of GEn1E Lifesciences, a board director of Moderna and Ring Therapeutics, and a senior advisor to Blackstone Life Sciences.

Previously, Francois was Chief Executive Officer of NPS Pharma. During his tenure, he transformed NPS Pharma into a leading global biotechnology company focused on delivering innovative therapies to patients with rare diseases. Before NPS, Francois was a venture partner at Care Capital. He also served on the North America Leadership Team of Aventis and its predecessor companies, holding several executive positions including senior vice president, integrated healthcare markets and North America medical and regulatory affairs. He led the global commercial operations at the Pasteur Vaccins’ division of Rhone-Poulenc.

Francois serves on the board of the Lebanese American University, the American Task Force for Lebanon, and as an advisor to LIFE Lebanon. He is the recipient of the Lebanese National Order of Merit, the Ernst and Young National Life Science Entrepreneur of the Year® award, and the Ellis Island Medal of Honor. 

Francois earned his French Doctorate in Medicine from St. Joseph University in Lebanon and his Physician Executive MBA from the University of Tennessee.